Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.398NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.163NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.3 (Theta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.38.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAVNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.1.4.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BM.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.77NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DN.1.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.626NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GA.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.75.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.524NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.38NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.15.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.59 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBRNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DJ.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AZ.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.193NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BL.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FP.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DA.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.68 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.16.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DN.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.28NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.5.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DN.1.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.84 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBSNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.2.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAHNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBJ.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EP.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CL.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBF.8.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAUNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAY.1.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.25.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used